We are committed at APIS Assay Technologies, to realise the clinical potential of systems biology and medicine in the diagnosis and personalisation of treatment. We seek to develop biomarkers that deliver significant improvements in the prediction and prevention of disease. There are 3 main workstreams of our business: 1. Biomarker Industrial Research Programme. This structured R&D programme undertakes industrial research on biomarker-based diagnostic assays, targeting oncology, inflammatory, cardiovascular, infectious disease and inherited disease areas. 2. The ‘Fast-Tracking’ of Biomarkers and Diagnostic Platforms for market sale. 3. The Contract Development activity operates as a distinct commercial service line, with focus on the tailored development of novel molecular diagnostic tests on new medical diagnostic platforms.
View Top Employees from APIS Assay Technologies Ltd.Website | http://www.apisassay.com |
Revenue | $2 million |
Employees | 99 (99 on RocketReach) |
Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
Competitors | 2BScientific Ltd., Caltag Medsystems Ltd., Core Precision, SAL Scientific Ltd., VH Bio |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular APIS Assay Technologies Ltd. employee's phone or email?
The APIS Assay Technologies Ltd. annual revenue was $2 million in 2024.
Joachim Schorr is the Founder and Executive Chairman of APIS Assay Technologies Ltd..
99 people are employed at APIS Assay Technologies Ltd..
The NAICS codes for APIS Assay Technologies Ltd. are [54, 541].
The SIC codes for APIS Assay Technologies Ltd. are [873, 87].